Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12204004rdf:typepubmed:Citationlld:pubmed
pubmed-article:12204004lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C1416655lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C0080024lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C0033713lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C1690540lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12204004lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12204004pubmed:issue3lld:pubmed
pubmed-article:12204004pubmed:dateCreated2002-8-30lld:pubmed
pubmed-article:12204004pubmed:abstractTextHuman piebaldism is a rare autosomal dominant disorder that comprises congenital patchy depigmentation of the scalp, forehead, trunk and limbs. It is caused by mutations in the cell-surface receptor tyrosine kinase gene (KIT, also c-kit). We screened three families and three isolated cases of piebaldism from different countries for mutations in the KIT gene using automated sequencing methods. We report six novel KIT point mutations: three missense (C788R, W835R, P869S) at highly conserved amino acid sites; one nonsense (Q347X) that results in termination of translation of the KIT gene in exon 6; and two splice site nucleotide substitutions (IVS13+2T>G, IVS17-1G>A) that are predicted to impair normal splicing. These mutations were not detected in over 100 normal individuals and are likely to be the cause of piebaldism in our subjects.lld:pubmed
pubmed-article:12204004pubmed:languageenglld:pubmed
pubmed-article:12204004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12204004pubmed:citationSubsetIMlld:pubmed
pubmed-article:12204004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12204004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12204004pubmed:statusMEDLINElld:pubmed
pubmed-article:12204004pubmed:monthSeplld:pubmed
pubmed-article:12204004pubmed:issn1098-1004lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:CartelNichola...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:HeathcoteKirs...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:SyrrisPetrosPlld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:DevriendtKoen...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:CarrozzoRomeo...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:ElçiogluNurse...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:GarrettChrist...lld:pubmed
pubmed-article:12204004pubmed:authorpubmed-author:McEntagartMer...lld:pubmed
pubmed-article:12204004pubmed:copyrightInfoCopyright 2002 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12204004pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12204004pubmed:volume20lld:pubmed
pubmed-article:12204004pubmed:ownerNLMlld:pubmed
pubmed-article:12204004pubmed:authorsCompleteYlld:pubmed
pubmed-article:12204004pubmed:pagination234lld:pubmed
pubmed-article:12204004pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:meshHeadingpubmed-meshheading:12204004...lld:pubmed
pubmed-article:12204004pubmed:year2002lld:pubmed
pubmed-article:12204004pubmed:articleTitleHuman piebaldism: six novel mutations of the proto-oncogene KIT.lld:pubmed
pubmed-article:12204004pubmed:affiliationMedical Genetics Unit, St George's Hospital Medical School, London, United Kingdom. psyrris@sghms.ac.uklld:pubmed
pubmed-article:12204004pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3815entrezgene:pubmedpubmed-article:12204004lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12204004lld:entrezgene